Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Adenosine Receptor Antagonism to Promote Breathing Plasticity in ALS
NCT05377424Phase 2Active, not recruiting
- Sponsor
- University of Florida
- Start
- Jun 2022
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Istradefylline in amyotrophic lateral sclerosis (ALS), sponsored by University of Florida. Started Jun 2022; status: active, not recruiting.
02
Drugs
Istradefylline
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT05377424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05377424.